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A Prospective Randomized Comparison of a Single Antibiotic 
(Moxalactam) Versus Combination Therapy (Gentamicin and 
Clindamycin) in Penetrating Abdominal TVauma 
Theodore Fifer, MD,* Farouck N. Obeid, MD,+ H. Mathilda Horst, MD,+ 
Victor J. Sorensen, MD,^  Larry D. Crots, RPh,* and Brack A. Bivins, MD* 
From July 1 to December 31, 1983, 50 consecutive patients undergoing abdominal exploration for 
penetrating abdominal trauma from stab and gunshot wounds were prospectively randomized to 
receive poslinjury, preoperative antibiotic coverage with moxalactam (2 g intravenously every 12 
hours) or a combination of gentamicin (3 to 5 mg/kg/day in three equal doses administered every eighl 
hours) and clindamycin (600 mg intravenously every six hours). No intraabdominal abscesses or 
wound infections developed, and no direct evidence of toxicity ofthe antibiotic regimens developed in 
either group. In the study group, moxalactam therapy was an effective alternative to the combination 
antibiotic regimen. The subsequently documented incidence of moxalactam-induced bleeding 
episodes precludes its use as a primary preventive antibiotic; however, other less toxic cephalosporins 
may demonstrate similar effectiveness. (Henry Ford Hosp MedJ 1988:36:52-5) 
Intraabdominal and wound infections are major sources of morbidity and mortality in patients sustaining penetrating ab-
dominal injury. In the pre-antibiotic era, penetrating abdominal 
injury with hollow viscus injury was almost universally fatal. 
Today, with modem techniques of transport, resuscitation, and 
postoperative management, the early deaths from hemorrhagic 
shock have been partly supplanted by late deaths from multiple 
system organ failure caused by intraabdominal infection (1-6). 
Controversy remains regarding the optimal regimen of peri-
operative antibiotics, and cost has become an increasingly 
important consideration in therapy for these patients. To obtain 
the wide spectrum of coverage necessary for abdominal injuries, 
multiple dmg regimens traditionally have been recommended 
(2,7,8). Treatment with one antibiotic has been found to be ef-
fective in comparison to multidrug regimens (9-15). Agents rec-
ommended are usually of the newer generation cephalosporin 
type due to their wide spectra including both anaerobes and 
aerobes (16-18). Some studies have found multiple drug reg-
imens to be superior to treatment with one antibiotic therapy of 
cefamandole or cefoxitin but not of moxalactam (19,20). 
In an effort to further clarify the role of single antibiotic ther-
apy in abdominal trauma, a moxalactam regimen was prospec-
tively compared to the more traditional two-drug combination 
including an aminoglycoside. 
Materials and Methods 
Fifty patients consecutively admitted for penetrating abdomi-
nal trauma to the Trauma Surgery Service from July I to De-
cember 31, 1983, were entered into a prospective randomized 
study. Informed consent regarding the nature of the study was 
obtained. The study, consent, and randomization were approved 
by the hospital's research review committee. 
Patients were randomized according to a predetermined se-
quence of regimen choices. Special packaging ofthe antibiotics 
concealed the identity of the selected regimen to the managing 
physicians; once the patient was entered into the study, the anti-
biotic regimen was revealed to the treating physicians. Antibi-
otic therapy prior to injury was cause for exclusion from the 
study. Group 1 included 25 patients who received gentamicin (3 
to 5 mg/kg/day in three equal doses administered every eight 
hours) and clindamycin (600 mg intravenously every six hours). 
Group 2 included 25 patients who received moxalactam (2 g 
intravenously every 12 hours); these patients also received phy-
tonadione (10 mg intramuscularly each week) as part of the pro-
tocol. Antibiotics were given according to the randomization 
schedule as soon as the decision to explore the abdomen was 
made. No other antimicrobials were given during the initial 
management period. Treatment was continued a minimum of 
three days for patients without injury to hollow viscus. Patients 
who were found to have hollow viscus injury at celiotomy re-
ceived antibiotics for a minimum of five days. Colonic injuries 
were managed primarily by exteriorization or colostomy. Pa-
tients were routinely explored via midline xiphipubic celiotomy. 
Their wounds were closed primarily in the absence of colonic 
injury. In the presence of colonic injury, delayed primary 
closure was used. 
Initial laboratory studies in all patients included complete 
blood count with differentials, serum electrolytes, and enzymes 
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Table 1 
Study Population Demographics 
Group 1 
Gentamicin/Clindamycin 
Group 2 
Moxalactam 
Age (years) 
Mean 27 27,1 
Range 17-57 18-66 
Gender 
Male 23 23 
Female 2 2 
Hospitalization (days) 
Mean 10,4 9,5 
Range 3-28 3-21 
Total 261 238 
Table 2 
Patterns of Injury 
Group I 
Gentamicin/Clindamycin 
Group 2 
Moxalactam 
Number of patients 25 25 
Hollow viscus injury 12 1 1 
Colon injury 4 2 
Gunshot wound 20 15 
Stab wound 5 10 
Solid organ injury 
(liver, spleen, pancreas. 
kidney, ovary) 7 15 
"Negative" laparototnies 5 7 
consisting of calcium, phosphoms, magnesium, SGOT, SGPT, 
lactic dehydrogenase alkaline phosphatase, creatinine phos-
phokinase, creatinine, total bilimbin, total protein, cholesterol, 
triglyceride, BUN, uric acid, and glucose. Urinalysis was ob-
tained. Coagulation parameters, prothrombin time, and partial 
thromboplastin time with platelet count were obtained. Cultures 
of intraperitoneal fluid, blood, and wound surface were obtained 
aerobically and anaerobically within four hours of antibiotic ad-
ministration. Organisms isolated in such cultures were tested 
for sensitivity to the antibiotics. In vitro susceptibility to moxa-
lactam was evaluated by determination of minimum inhibitory 
concentration. The Kirby-Bauer disk diffusion method was 
used to test sensitivity of isolated organisms to gentamicin 
and clindamycin. 
Inpatient follow-up included daily physical examinations, vi-
tal sign determinations every eight hours, and selected labora-
tory studies during the study period and three times weekly after 
the study period until discharge. Postdischarge follow-up was 
continued for at least two weeks. Failure of antibiotic therapy 
was defined as an oral temperature greater than 38°C on two 
occasions more than six hours apart, a WBC count greater 
than 20,000/pL, wound infection requiring drainage, intra-
abdominal abscess formation, or positive blood cultures. 
Results 
Population demographics are summarized in Table I . The 25 
patients who received gentamicin and clindamycin (group 1) 
ranged in age from 17 to 57 years (mean 27 years). The 25 pa-
tients who received moxalactam (group 2) ranged in age from 18 
to 62 years (mean 27.1 years). Both groups contained 23 men 
and two women. Patterns of injury are summarized in Table 2. 
Twelve of the patients randomized to the gentamicin/clin-
damycin group had hollow viscus injury at celiotomy, with four 
ofthe patients sustaining injuries to the colon. Eleven ofthe pa-
tients receiving moxalactam had hollow viscus injury, with two 
of the patients sustaining injuries to the colon. Of the patients 
randomized to the gentamicin/clindamycin group, 20 sustained 
gunshot wounds and five had stab wounds. Of the patients in 
the moxalactam group, 15 sustained gunshot wounds and ten 
had stab wounds. No stab wounds resulted in colonic injury in 
either group. 
No patients in this study developed an infection requiring sur-
gical intervention. Several patients had positive peritoneal or 
wound cultures. Four patients receiving moxalactam had 
positive peritoneal cultures as opposed to three patients in the 
gentamicin/clindamycin group. One patient receiving moxalac-
tam after multiple gunshot wounds to the chest, abdomen, and 
extremities had a positive wound culture for an enterococcus 
and developed a postoperative fever. The fever, however, re-
solved with intensive pulmonary toilet, and no obvious focus of 
enterococcal infection was identified. 
After study antibiotics were discontinued, two patients 
receiving moxalactam had positive wound cultures for an 
enterococcus and Staphylococcus epidermidis but wound infec-
tion requiring drainage did not develop. Another patient receiv-
ing gentamicin and clindamycin had a positive wound culture 
for Pseudomonas aeruginosa and Staphylococcus epidermidis 
but wound infection requiring intervention did not develop. 
No overt symptoms of toxicity developed in any patient. One 
patient receiving moxalactam had a transient elevation of semm 
creatinine (> 2.0 mg/dL), which resolved within 48 hours with-
out specific change in therapy. Abnormal coagulation param-
eters, which also resolved without specific intervention, were 
observed in two patients receiving gentamicin and clindamycin 
and one patient receiving moxalactam. No clinical episodes of 
bleeding or ototoxicity were noted. 
Discussion 
Antimicrobials have four clinical applications: 1) primary 
therapy, as in the treatment of pneumonia; 2) prophylaxis, as in 
coverage for an elective operation (where antibiotics are given 
prior to contamination); 3) preventive, as when contamination 
has already occurred; and 4) adjunctive, as in the management 
of an abscess where drainage is the primary therapy. Antibiotic 
treatment of the traumatized patient begins after injury (and 
therefore after contamination) and must be considered preven-
tive. The therapy should be directed against pathogens most 
likely to cause infection, such as the microflora residing in the 
gut of the acutely traumatized patient. While the normal stom-
ach and proximal small bowel contain relatively few bacteria in 
most patients, the distal small bowel and colon contain a high 
concentration (up to 10" organisms per gram) (21,22) of aerobic 
and anaerobic species including Bacillus fragilis, aerobic en-
terococci, Pseudomonas species, and anaerobic Streptococcus 
and Fusobacterium. In patients with postsurgical intraab-
dominal abscesses, mixed flora of anaerobes and aerobes are 
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recovered five times more frequently than either aerobes or an-
aerobes alone (21). Theories of microbial synergism abound (2). 
When risk factors of penetrating abdominal trauma were exam-
ined in 338 patients, colon injury and wounding by gunshot 
emerged as significant risk factors for trauma-related infections 
(5). In an experimental model of colonic perforation, 29 dif-
ferent regimens were compared for incidence of fatal perito-
nitis and abscess formarion (11). The most effective regimens 
were those which combined agents effective against coliforms 
(aerobes) and Bacillus fragilis (11,13). 
In a study of 295 patients sustaining penetrating abdominal 
trauma, those who received antibiotics preoperatively had a 
significantiy lower incidence of wound infection, abscess, and 
sepsis (23). The question of how long to continue therapy 
postoperatively has not been resolved. In a prospective ran-
domized study of 82 patients requiring celiotomy for penetrating 
abdominal trauma, a 12-hour postoperative course of antibiotics 
was comparable to a five-day course in the prevention of 
postoperative infection (4). Statisticafly significant differences 
of infection rate were not found between preoperative only and 
preoperative plus 24-hour antibiotic regimens in a series of 360 
patients sustaining abdominal trauma (14). 
Although antibiotics reduce the risk of infection in abdominal 
trauma, the choice of antibiotics remains controversial. Com-
bination therapy with an aminoglycoside has been popular, even 
though aminoglycoside antibiotics tend to produce nephrotox-
icity and ototoxicity. Of parricular significance is that the 
ototoxic damage is often permanent due to destruction of 
cochlear hair cells. The new cephalosporins have antimicrobial 
spectra which compare favorably to that of combination therapy 
and may be less toxic (16,17,24). 
Moxalactam has been noted to cause blood clotting derange-
ments. The mechanisms are: 1) an acute interference with 
vitamin K metabolism superimposed on a chronic vitamin K de-
ficiency, and 2) platelet dysfunction. Supplemental vitamin K 
reverses humoral clotting derangements (25). The frequency of 
moxalactam-induced bleeding events, most ofwhich are se-
rious, has been reported to be 2.5% for those receiving mox-
alactam for four or more days (24). Because of this incidence, 
use of moxalactam as a primary preventive antibiotic has been 
abandoned. 
In our series, wound infection requiring surgical intervention 
did not develop even though positive cultures of the wounds 
were obtained. Culture of an organism from a wound does not 
represent infection but does indicate the presence of that organ-
ism in sufficient numbers to produce colony-forming units (26). 
The probability of infection in a wound is directly proportional 
to inoculum size and pathogen virulence and inversely propor-
tional to local and systemic defenses (27). The results ofthis 
study provide support for previous reports indicating that broad 
spectrum cephalosporin therapy is clinically equivalent to com-
bination therapy in abdominal trauma (9,11,13,14). 
The populations included herein are insufficient to eliminate 
the possible existence of a type 2 error. Populations sizable 
enough to determine the exact difference in rates of post-
penetrating abdominal trauma infections between the two reg-
imens would be difficult to achieve given the overall low rate of 
infection with adequate surgical therapy. One obstacle to routine 
use of the newer cephalosporins has been the perceived high cost 
of these antibiotics. In a previous study, the total cost of antibi-
otic therapy for patients with penetrating abdominal trauma was 
approximately $125 higher per patient for the combination of 
gentamicin and clindamycin versus single agent therapy of mox-
alactam. This study considered cost per dose, personnel time, 
supply cost, and the cost of laboratory monitoring (28). 
In our study, 2 g of moxalactam given intravenously every 12 
hours was found to be of comparable efficacy to a gentamicin/ 
clindamycin combination. Unfortunately, coagulopathy associ-
ated with use of moxalactam is serious enough to preclude its 
use in a preventive setting. Nevertheless, single antibiotic reg-
imens with less toxic third generation cephalosporins appear to 
be a fruitful area for future research. 
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